Other than to say both ANS and SDL can move forward, I have no further interest in specifically posting on SDL threads.You'll have to perform your own research, but you might want to check out the ANS threads from the last few weeks as a heads up.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market